A predictive MDR CE class 2a medical device for preventive cardiovascular medicine
IMAGEENS has developed Europe’s first clinically-validated software as a medical device enabling the measurement of biomarkers linked to patients’ cardiovascular risk and cardiovascular aging. Our software as a medical device has successfully received the notoriously challenging class 2a approval under the EU’s new Medical Device Regulation (EU MDR).
Enabling the measurement of predictive biomarkers
linked to cardiovascular risk & aging
Based on a robust, clinically
validated platform
We share our knowledge & approach with leading healthcare institutions to build more Predictive Clinical Decision AI
Our mission is to help physicians make better clinical decisions for their patients by making the most of their imaging data. By working with leading healthcare institutions, we: